GlassScriptPhysician profile
Hari O Gupta
NPI 1437597325
$26,429.48
in general payments reported to CMS, 2019-2025
12 companies · $2,935 in 2025
The $2,935 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $5,237 · 2021: $148 · 2022: $1,961 · 2023: $2,033 · 2024: $363 · 2025: $2,935.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,892 · Food and Beverage: $1,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,892.35 |
| Food and Beverage | $1,438.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $11,036.60 | 2019-2025 | |
| Smith+Nephew, INC. | $6,957.59 | 2019-2025 | Coblation, Bone Anchors With Arthroscopic Delivery System |
| Fx Shoulder Solutions, INC | $3,812.60 | 2020-2023 | |
| Seapearl East, INC | $2,017.81 | 2024-2025 | |
| Advanced Orthopaedic Solutions, INC. | $1,387.17 | 2020 | |
| Stryker Corporation | $950.69 | 2019-2024 | Vitoss |
| Catalyst Orthoscience | $125.00 | 2024 | Catalyst Csr Shoulder System |
| Zimmer Biomet Holdings, INC. | $60.90 | 2022 | |
| Endo Pharmaceuticals INC. | $25.15 | 2020-2021 | |
| Depuy Synthes Sales INC. | $20.75 | 2022 | |
| Abbvie INC. | $20.22 | 2022 | |
| Glaxosmithkline, LLC. | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hari Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.